Andrea Cossarizza holds a PhD in Oncology from the
Universities of Bologna and Modena, with a Specialization in Clinical Pathology
and Immunohematology from the University of Modena and Reggio Emilia. As a
medical student, his interest in immunology led him to the Basel Institute of
Immunology and then to the New York University Medical Center. After working at several different institutions (Charing Cross Sunley Res. Ctr., London; Univ. Cochin,
Paris; University of California at Los Angeles-UCLA), he became Associate
Professor of General Pathology and Immunology at the University of Modena and
Reggio Emilia in 1998 and was appointed Full Professor in 2010. He is also Director
of the School of Specialization in Clinical Pathology and Clinical Biochemistry; he was President of the International Society for Advancement in Cytometry (ISAC) in 2018-2020 and is now Past President. As of January 2024, he has published >440 papers in peer-reviewed international journals, and his current scientific interests are the characterization of the immune response and the search for predictive
markers in patients treated with biological drugs; immune alterations during
different diseases, in particular, HIV and SARS-CoV2 infections and autoimmune
disorders; immunological changes during aging and longevity; the role of mitochondria during apoptosis; and the importance of mitochondrial DNA in a variety
of pathologies.
Andrea Cossarizza holds a PhD in Oncology from the
Universities of Bologna and Modena, with a Specialization in Clinical Pathology
and Immunohematology from the University of Modena and Reggio Emilia. As a
medical student, his interest in immunology led him to the Basel Institute of
Immunology and then to the New York University Medical Center. After working at several different institutions (Charing Cross Sunley Res. Ctr., London; Univ. Cochin,
Paris; University of California at Los Angeles-UCLA), he became Associate
Professor of General Pathology and Immunology at the University of Modena and
Reggio Emilia in 1998 and was appointed Full Professor in 2010. He is also Director
of the School of Specialization in Clinical Pathology and Clinical Biochemistry; he was President of the International Society for Advancement in Cytometry (ISAC) in 2018-2020 and is now Past President. As of January 2024, he has published >440 papers in peer-reviewed international journals, and his current scientific interests are the characterization of the immune response and the search for predictive
markers in patients treated with biological drugs; immune alterations during
different diseases, in particular, HIV and SARS-CoV2 infections and autoimmune
disorders; immunological changes during aging and longevity; the role of mitochondria during apoptosis; and the importance of mitochondrial DNA in a variety
of pathologies.